SEC Form 4 · accession 0001093557-16-000632
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Robert Pacelli
Officer — EVP, Strategy & Corp. Dev.
Period of report
Aug 8, 2016
Accepted (ET)
Aug 9, 2016 · 9:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 8, 2016 | M | 4 | $11.33 | A | 161,922 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy) | $11.33 | Aug 8, 2016 | M | 4 | D | Aug 8, 2007 | Aug 8, 2016 | Common Stock | 4 | 0 | D |
Explanation of responses
- F1Included in this number are 91,667 unvested restricted stock units, 38,000 of which were granted on March 8, 2016 and shall vest through March 8, 2019, 30,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018 and 23,667 of which were granted on March 8, 2014 and shall vest through March 8, 2017.